BRAINSTORM CELL THERAPEUTICS INC.
1745 Broadway, 17th Floor
New York, NY 10019
June 27, 2018 |
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Christine Westbrook
RE: | Brainstorm Cell Therapeutics Inc. |
Registration Statement on Form S-3
Filed June 8, 2018
File No. 333-225517
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Brainstorm Cell Therapeutics Inc. (the “Company”) hereby respectfully requests that the effectiveness of the above-captioned Registration Statement on Form S-3 be accelerated to Friday, June 29, 2018, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
Any questions regarding this request should be addressed to Thomas B. Rosedale, Esq., at BRL Law Group LLC at (617) 399-6931.
Very truly yours, | |||
Brainstorm Cell Therapeutics Inc. | |||
/s/ Chaim Lebovits | |||
By: Its: | Chaim Lebovits President and Chief Executive Officer |
cc: | Thomas B. Rosedale, Esq. |
(BRL Law Group LLC)